DRUG vs. NVDA
Compare and contrast key facts about Bright Minds Biosciences Inc (DRUG) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DRUG or NVDA.
Correlation
The correlation between DRUG and NVDA is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DRUG vs. NVDA - Performance Comparison
Key characteristics
DRUG:
1.24
NVDA:
1.62
DRUG:
24.17
NVDA:
2.16
DRUG:
3.84
NVDA:
1.28
DRUG:
18.51
NVDA:
3.39
DRUG:
49.64
NVDA:
9.39
DRUG:
36.43%
NVDA:
9.76%
DRUG:
1,461.78%
NVDA:
56.78%
DRUG:
-97.67%
NVDA:
-89.73%
DRUG:
-32.94%
NVDA:
-6.83%
Fundamentals
DRUG:
$226.37M
NVDA:
$3.41T
DRUG:
-$0.45
NVDA:
$2.53
DRUG:
$0.00
NVDA:
$91.17B
DRUG:
-$36.23K
NVDA:
$69.14B
DRUG:
-$1.07M
NVDA:
$60.32B
Returns By Period
The year-to-date returns for both stocks are quite close, with DRUG having a 3.83% return and NVDA slightly lower at 3.68%.
DRUG
3.83%
1.69%
3,531.07%
1,900.00%
N/A
N/A
NVDA
3.68%
1.10%
8.37%
100.51%
80.65%
74.59%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DRUG vs. NVDA — Risk-Adjusted Performance Rank
DRUG
NVDA
DRUG vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DRUG vs. NVDA - Dividend Comparison
DRUG has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRUG Bright Minds Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
DRUG vs. NVDA - Drawdown Comparison
The maximum DRUG drawdown since its inception was -97.67%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for DRUG and NVDA. For additional features, visit the drawdowns tool.
Volatility
DRUG vs. NVDA - Volatility Comparison
Bright Minds Biosciences Inc (DRUG) and NVIDIA Corporation (NVDA) have volatilities of 25.24% and 24.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DRUG vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Bright Minds Biosciences Inc and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities